(HealthDay News) -- Using a combination of diuretics and ACE inhibitors to bring home the bacon daub compel in people with write 2 diabetes can back up defend against heart disease according to new data released Sunday. The combined therapy administered as part of a worldwide chew over known as ADVANCE reduced the risk of dying from heart disease by 18 percent."If the benefits seen in ADVANCE were applied to just half the population with diabetes worldwide more than a million deaths would be avoided over five years. For these reasons there is now a inspect for considering such treatment routinely for patients with write 2 diabetes," study author John Chalmers from The George initiate at the University of Sydney in Australia said in a prepared statement. By 2030 an estimated 350 million people will be living with diabetes worldwide. Heart disease kills two out of three people with diabetes who are at increased risk of touch heart attacks and related conditions such as degenerative eye disease. Blood compel management is recommended to decrease the assay of heart disease. The new findings comes from the ADVANCE trial which tracked more than 11,100 people with type 2 diabetes from 215 medical centers in 20 countries for four years. The participants all 55 or older received either a combination of the ACE inhibitor perindopril and the diuretic indapamide or a placebo. Over the course of the four years the researchers found that populate with the combined therapy had an average reduction in systolic daub compel of 5-6 mm Hg and diastolic daub pressure of 2 mm Hg compared with the placebo group. populate who got the combined therapy were 9 percent less likely to have a heart disease event such as touch or heart contend over the treatment period. They were also 18 percent less likely to die from heart disease and 14 percent less likely to die from any create. The researchers noted that the impact of the combined therapy occurred regardless of the participants' blood pressure at the beginning of the chew over. The study was released online Sunday by The Lancet to coincide with a presentation of the investigate at the European Society of Cardiology meeting in Vienna. In an accompanying commentary in the journal. Dr. Norman Kaplan a hypertension expert from the University of Texas Southwestern Medical Center at Dallas had a caution on the findings."The fixed combination of perindopril and indapamide could be the best possible protector against hyper-tension-related consequences for patients with type 2 diabetes but I believe that other drugs if they lower daub pressure as much and do not undergo metabolic side-effects would be as protective as this combination treatment," he said. And he added. "As has been said many times before by many experts: In most circumstances lowering the blood pressure is what counts not the way by which it is lowered."More informationTo learn more about diabetes and heart disease tour the.
Cruise 4 Cash -
Detective Sherlock -
Free Bid Auctions -
Expert Poker Tips -
Shop 4 Money
Win Any Lottery -
Repo Car Search -
Psychics 4 Free -
High Quality Games -
Driving 4 Dollars
Related article:
http://dreddyclinic-alkaline.blogspot.com/2007/09/blood-pressure-drug-combo-helps.html
comments | Add comment | Report as Spam
|